When could the first COVID-19 vaccines be given in the US?
Given the regulatory timeline, Dec. 13 is the earliest the first round of vaccine against the coronavirus could start to be given to select Americans.
Related Articles
Randomised controlled trials evaluating artificial intelligence in clinical practice: a scoping review
This scoping review of randomised controlled trials on artificial intelligence (AI) in clinical practice reveals an expanding interest in AI across clinical specialties and locations.…
Welcoming the Era of Gene Editing in Medicine | NEJM
Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But…
Do cancer patients get enough time off work? Most struggle to balance finances, job duties
Younger cancer patients are more likely to struggle with medical bills, skip needed care due to cost, the American Cancer Society study said
Welcoming the Era of Gene Editing in Medicine | NEJM
Recent approvals of exa-cel for treatment of sickle cell disease and transfusion-dependent β-thalassemia mark the dawn of the era of gene editing in medicine. But…
Dozens sue saying Ozempic, other weight loss and diabetes drugs cause harmful side effects
Dozens of lawsuits allege drugmakers failed to notify patients about side effects of popular diabetes or weight loss drugs such as Ozempic, Wegovy and Mounjaro.
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes | NEJM
Obesity and type 2 diabetes are prevalent in patients with heart failure with preserved ejection fraction and are characterized by a high symptom burden. No…
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells
Nature – Tumour-derived prostaglandin E2, signaling through its receptors EP2 and EP4, is shown to restrain the responses of tumour-infiltrating stem-like TCF1+CD8+ T lymphocytes, and…
Transient loss of Polycomb components induces an epigenetic cancer fate
Nature – A transient perturbation of transcriptional silencing mediated by Polycomb proteins is sufficient to induce an epigenetic cancer cell fate in Drosophila in the…
Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo
Nature – Topobiologically complex mini-colons—which enable the faithful in vitro recapitulation of colorectal cancer tumorigenesis and its environmental determinants—offer the…
Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes | NEJM
Obesity and type 2 diabetes are prevalent in patients with heart failure with preserved ejection fraction and are characterized by a high symptom burden. No…